Jitalia17 Resilient Labor Market, Stubborn Inflation Test Team Fed’s Rate Cut Path 2023 finished on a powerful note, fueled by near-historic performance in November and December, pushing the Bloomberg US Aggregate Bond Index into positive territory and potentially setting the tone for an ongoing recovery from 2022’s challenges. Alas, this was not to be the…
Olemedia Market Commentary In a volatile first quarter of 2024, markets moved choppily higher, delivering positive returns across most regions and countries. US stocks rose +10% (as measured by the Russell 3000 Index), led by large-cap stocks, which were likewise up just over +10%, followed by mid caps (+9%) and small caps (+5%), as measured…
AndreyPopov/iStock via Getty Images Market Commentary In a volatile first quarter of 2024, markets moved choppily higher, delivering positive returns across most regions and countries. US stocks rose +10% (as measured by the Russell 3000 Index), led by large-cap stocks, which were likewise up just over +10%, followed by mid caps (+9%) and small caps…
shapecharge Investment Thesis Diamond Hill (NASDAQ:DHIL) is going to report its FY23 numbers at the beginning of February. I wanted to take a look at what has happened since I covered the company last, which was March ’23. The company’s share price went nowhere compared to the overall market, as the company continued to see…
CIPhotos Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is a precision oncology company targeting genetically defined cancers. It calls its approach the Masterkey approach, which aims to provide one solution for many types of cancer mutations and address the disease in a much broader range of patients than current precision therapies can access. Its oral therapies are…
Bjoern Wylezich/iStock via Getty Images Thesis To kick off 2024 I decided to take a look at the energy markets from a different perspective. The market doesn’t always get things right, so I took a look at the worst performers over the course of 2023. I screened both American and Canadian energy companies with a…
Coinbase-backed Project Diamond will leverage the Base L2 network and the Coinbase technology stack to enable institutional investors to tokenize and trade real-world assets. Leading United States cryptocurrency exchange by registered users and average daily traded volume Coinbase Global Inc (NASDAQ: COIN), has continued to widen its global market reach with Binance Holdings Ltd under…
ProArtWork/E+ via Getty Images Introduction Adyen (OTCPK:ADYEY) has been on my watchlist for a couple of years now, but I’ve never really looked into the company for one reason and one reason only: overvaluation. The stock has always traded at a large premium which is why I avoided it entirely. However, due to recent events,…
Reptile8488/iStock via Getty Images Market Commentary Markets were positive in Q2 2023, with US stocks rising over 8% (as measured by the Russell 3000 Index), bringing YTD gains to roughly 16%. Continuing the YTD trend, large-cap stocks led in Q2, rising almost 9%, while mid-cap stocks rose nearly 5% and small-cap stocks rose just over…
ipopba Market Commentary Markets were positive in Q2 2023, with US stocks rising over 8% (as measured by the Russell 3000 Index), bringing YTD gains to roughly 16%. Continuing the YTD trend, large-cap stocks led in Q2, rising almost 9%, while mid-cap stocks rose nearly 5% and small-cap stocks rose just over 5% (as measured…
Sharkyjones Note: I have previously covered Diamond Offshore Drilling, Inc. (NYSE:DO), so investors should view this as an update to my earlier articles on the company. Two weeks ago, leading offshore driller Diamond Offshore Drilling (“Diamond Offshore”) reported better-than-expected second quarter 2023 results but according to statements made by management on the conference call, the…
industryview Investment Summary Looking at just the P/E of Diamond Offshore Drilling Inc (NYSE:DO) I think most investors would quite quickly just turn away as it’s sitting at 281. But this is doing an injustice to the company as the earnings going forward are extremely promising. In 2024 the EPS is to jump to $1.39…
Mohammed Haneefa Nizamudeen Shares of precision cancer medicine developer Black Diamond Therapeutics (NASDAQ:BDTX) have lost over three-quarters of their value since IPO was priced at $19 in 2020. However, they are up 94% so far in 2023 after the company posted a positive data update in June for lead drug candidate BDTX-1535 in advanced non-small…